Article
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
15 Dec 2004
Abstract excerpt
BACKGROUND: Colon adenocarcinomas are refractory to a number of widely used anticancer agents. Multifactorial mechanisms have been implicated in this intrinsically resistant phenotype, including deregulation of cell death pathways. In this regard, the p53 protein has a well established role in the control of tumor cell response to DNA damaging agents; however, the relationship between p53-driven genes and drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
